Cormorant Asset Management, LP 的 Form 4/A 修正申報
修正Erasca, Inc.ERAS，2022/12/21 申報
- 申報編號
- 0000929638-22-001904
- 申報時間
- 2022/12/21 16:33 ET
- 交易日
- 2022/12/13
- 申報延遲
- 8 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
- 原始申報日
- 2022/12/20
這份申報列了 1 筆非衍生性交易。公開市場買進合計 $200.0 萬。交易後 8 天申報。
這份修正申報取代了 0000929638-22-001901（2022/12/20 申報）。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Cormorant Asset Management, LPCIK 0001583977 | 董事 |
| Chen BihuaCIK 0001599214 | 董事 |
| Cormorant Global Healthcare Master Fund, LPCIK 0001618442 | 董事 |
| Cormorant Private Healthcare Fund II, LPCIK 0001747677 | 董事 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2022/12/13 | Common Stock | P買進取得 | +307,692 | $6.50 | +$1,999,998 | 10,813,246 | 間接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
Shares reported herein are held by Cormorant Global Healthcare Master Fund, LP (the "Master Fund"), Cormorant Private Healthcare Fund II, LP ("Fund II"), and a managed account (the "Account"). Cormorant Asset Management, LP ("Cormorant") serves as the investment manager of the Master Fund, Fund II, and the Account. Bihua Chen serves as manager of the general partner of Cormorant. Ms. Chen disclaims beneficial ownership of the shares reported herein except to the extent of her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that Ms. Chen is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose.
- F2
Represents (i) 2,986,402 shares of Common Stock held by the Master Fund, (ii) 7,716,444 shares of Common Stock held by Fund II, and (iii) 110,400 shares of Common Stock held by the Account.
- F3
Shares reported herein as purchased on December 9, 2022 were purchased by the Master Fund.
- F4
Stock option grant for 166,666 shares, 41,667 shares of which become exercisable on 3/16/2022 and 124,999 shares of which become exercisable thereafter in equal monthly installments through 3/16/2025.
- F5
Stock options granted to Bihua Chen, in her capacity as a director of the Issuer.
備註
This amendment is being filed to clarify that the Form 4 filed by the Reporting Persons on December 20, 2022 was signed on such date and to correct a typographical error in the Date of Earliest Transaction reported in such Form 4.